IPO Plus

₹145.35

▼ -6.59 -4.34%

As of 06 Nov 2026 · delayed

NSE Listed

Bio Medica Laboratories Limited (BMLL)

Volume: 26,000Avg Vol 1W: 28,000Avg Vol 1M: 33,55052W Range:₹101.5₹181
Key Ratios
Checked 2h ago
Market Cap—
Current Price₹145.35
Previous Close₹151.94
High / Low (52w)₹181 / ₹101.5
Volume26,000
Avg Vol (1W)28,000
Avg Vol (1M)33,550
Stock P/E0
Book Value₹49.24
Dividend Yield0%
ROE66.48%
ROA0%
Revenue (TTM)₹43 Cr
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹0
P/B2.95
Debt / Equity1.33
50 DMA₹156.35
200 DMA₹146.12
Day change-4.34%
Price Chart
₹145.35▲ 25.52% · 1Y
₹177₹10621.9L
2026-05-29
2026-11-06

20-day avg volume: 34K shares

Pros
  • Healthy return on equity of 66.5%.
  • Company is almost debt-free.
Profit & Loss (Annual)
MetricMar 2023Mar 2024Mar 2025Mar 2026
Revenue₹16 Cr₹15 Cr₹38 Cr₹43 Cr
EBITDA₹1 Cr₹5 Cr₹14 Cr₹19 Cr
Net Profit₹0 Cr₹2 Cr₹10 Cr₹12 Cr
EPS0.362.7210.5712.95
Balance Sheet
MetricMar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹18 Cr₹20 Cr₹39 Cr₹73 Cr
Total Liabilities₹15 Cr₹15 Cr₹24 Cr₹53 Cr
Equity₹2 Cr₹5 Cr₹15 Cr₹20 Cr
Total Debt————
Cash Flow
MetricMar 2023Mar 2024Mar 2025Mar 2026
Operating₹3 Cr₹2 Cr₹-1 Cr₹-2 Cr
Investing₹-2 Cr₹-2 Cr₹0 Cr₹-2 Cr
Financing₹-2 Cr₹0 Cr₹5 Cr₹8 Cr
Free Cash Flow₹3 Cr₹2 Cr₹-1 Cr₹-2 Cr
Shareholding
Promoter 67.7% Institutions 2.59% Public 29.71%
Efficiency & Working Capital
ROCE62.9%
Interest Coverage8.1
Dividend Payout—
Debtor Days92 d
Inventory Days308 d
Payable Days47 d
Cash Conversion Cycle353 d
Working Capital Days400 d
Shareholding Details

As of 2026-09-30

Promoter67.7%
FII4.8%
DII3.6%
Institutions8.4%
Public23.9%
Promoter Pledge0%
No. of Shareholders331
Shareholding Pattern

Quarterly — figures in %. Latest 5 quarters.

PeriodAug 2025Aug 2025May 2026May 2026Sept 2026
Promoters100%100%67.7%67.7%67.7%
FIIs0%0%0.3%0.3%4.8%
DIIs0%0%2.3%2.3%3.6%
Public0%0%29.7%29.7%23.9%
Promoter Pledge0%0%0%0%0%
No. of Shareholders771,1951,195331
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Mukesh MehtaShareholding of Promoter and Promoter Group33.9%42,56,316
Pradeep MehtaShareholding of Promoter and Promoter Group33.9%42,56,225
Tiger Strategies Fund -iPublic Shareholding2.3%2,90,000
Pine Oak Global FundPublic Shareholding2.1%2,60,000
Eminence Global Fund Pcc- Eubilia Capital Partners Fund IPublic Shareholding1.6%2,00,000
Alok KumarPublic Shareholding1.6%2,00,000
Base Engineering LlpPublic Shareholding1.6%2,00,000
Capital Trade Links LimitedPublic Shareholding1.3%1,64,000
Mohammad Ashraf QureshiPublic Shareholding1.3%1,60,000
Rathod Manoj Chhaganlal HufPublic Shareholding1.1%1,35,000
Jayant Babulal BokadiaPublic Shareholding1%1,30,000
Dhanadeepa Consultant Private LimitedPublic Shareholding1%1,28,000
Garima MehtaShareholding of Promoter and Promoter Group0%92
Anju MehtaShareholding of Promoter and Promoter Group0%92
Tara MehtaShareholding of Promoter and Promoter Group0%92
Lokesh JainShareholding of Promoter and Promoter Group0%92
Board of Directors
NameDesignationYear
Pradeep MehtaED / MD / Promoter2025
Mukesh MehtaWTD & Executive Director2025
Surabhi MahajanNon Executive Director2025
Divya KhandelwalIndependent Non Exe. Director2025
Sumeet BansalIndependent Non Exe. Director2025
Rahul KumarCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹101699
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-27Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000404
2025000303
2025000000
Company Information
Incorporated2015
Investor Email[email protected]
🌐 www.biomedica.co.in ↗

📍 Plot No.11B-11C Sector-E, Sanwer Rd Industrial Area, Indore, Madhya Pradesh, 452015

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App